Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Venture capital firm invests in medical device manufacturer
August 25th, 2005
New Enterprise Associates (NEA) announced that it has invested in SurgRx, a medical device manufacturer based in Palo Alto, California. SurgRx is the developer of the EnSeal System, a proprietary, U. S. Food and Drug Administration (FDA)-approved technology that empowers surgeons to cut and seal blood vessels and tissue quickly, efficiently, and with virtually no unwanted effects. NEA led this $21 million round of Series E financing, which will be used to aid the company in marketing EnSeal products internationally. "The EnSeal System benefits physicians across a broad range of surgical applications," said Sigrid Van Bladel PhD, NEA partner and newly...
Source: Women's Health Weekly (2005-08-25)
|
